Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 52,845,596
  • Shares Outstanding, K 399,770
  • Annual Sales, $ 803,400 K
  • Annual Income, $ -747,060 K
  • 60-Month Beta 1.48
  • Price/Sales 65.83
  • Price/Cash Flow N/A
  • Price/Book 20.44
Trade MRNA with:

Options Overview

Details
  • Implied Volatility 94.79%
  • Historical Volatility 69.17%
  • IV Percentile 39%
  • IV Rank 25.67%
  • IV High 170.07% on 03/16/20
  • IV Low 68.80% on 01/20/21
  • Put/Call Vol Ratio 0.90
  • Today's Volume 22,727
  • Volume Avg (30-Day) 50,560
  • Put/Call OI Ratio 0.75
  • Today's Open Interest 371,330
  • Open Int (30-Day) 345,751

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 2.24
  • Number of Estimates 5
  • High Estimate 2.84
  • Low Estimate 1.95
  • Prior Year -0.35
  • Growth Rate Est. (year over year) +740.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
121.12 +9.14%
on 03/05/21
189.26 -30.15%
on 02/08/21
-44.05 (-24.99%)
since 02/05/21
3-Month
102.66 +28.76%
on 12/31/20
189.26 -30.15%
on 02/08/21
-20.33 (-13.33%)
since 12/04/20
52-Week
19.31 +584.57%
on 03/13/20
189.26 -30.15%
on 02/08/21
+104.18 (+371.94%)
since 03/05/20

Most Recent Stories

More News
Moderna Announces Supply Agreement to Provide 13 Million Doses of COVID-19 Vaccine Moderna to the Philippines

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a supply agreement with the Government of The Philippines for 13 million...

MRNA : 132.19 (-0.08%)
Vaccine Miracles: Does JNJ Kill the Profit Path for MRNA and NVAX?

New vaccine entrant gets approval before Novavax, while herd immunity ideas put sales in doubt.

JNJ : 156.10 (+1.98%)
MRNA : 132.19 (-0.08%)
NVAX : 174.84 (+10.59%)
Japan extends virus emergency for 2 weeks for Tokyo area

TOKYO (AP) — Japanese Prime Minister Yoshihide Suga announced that his government is extending a state of emergency in the Tokyo region for another two weeks because its medical systems are still strained...

MRNA : 132.19 (-0.08%)
PFE : 34.39 (+0.56%)
USANA Health (USNA) Soars to 52-Week High, Time to Cash Out?

USANA Health (USNA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

USNA : 101.39 (+1.25%)
MRNA : 132.19 (-0.08%)
HLUYY : 37.5600 (-0.53%)
CLGN : 13.07 (+6.35%)
5 High Earnings Yield Picks That Command Your Attention

Level up your portfolio with high earnings yield stocks including ArcelorMittal (MT), Moderna, (MRNA), Shell (RDS.A), Magna (MGA), Winnebago (WGO).

MGA : 87.80 (+3.20%)
MRNA : 132.19 (-0.08%)
MT : 24.56 (+4.16%)
RDS.A : 43.85 (+3.35%)
WGO : 73.96 (+4.01%)
Moderna Announces New Drug Application Submitted to Import and Distribute Moderna's COVID-19 Vaccine Candidate in Japan

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Takeda Pharmaceutical Co., Ltd (NYSE: TAK) submitted a New Drug Application...

MRNA : 132.19 (-0.08%)
TAK : 17.47 (+0.17%)
Moderna and IBM Plan to Collaborate on COVID-19 Vaccine Supply Chain and Distribution Data Sharing

and , /PRNewswire/ -- Today, Moderna (Nasdaq: MRNA) and IBM (NYSE: ) announced their intentions to explore technologies, including artificial intelligence, blockchain and hybrid cloud, that could help...

IBM : 122.83 (+2.26%)
MRNA : 132.19 (-0.08%)
Arena (ARNA) Tumbles as Mid-Stage Gastrointestinal Study Fails

Arena's (ARNA) mid-stage study evaluating olorinab in patients with abdominal pain due to irritable bowel syndrome fails to meet primary endpoint.

MRNA : 132.19 (-0.08%)
ARNA : 73.57 (+2.88%)
LXRX : 6.78 (+1.80%)
RGEN : 186.19 (+1.63%)
Thinking about trading options or stock in Apple, Moderna, General Electric, Lyft, or Tripadvisor?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, MRNA, GE, LYFT, and TRIP.

AAPL : 121.42 (+1.07%)
LYFT : 64.12 (+3.64%)
MRNA : 132.19 (-0.08%)
TRIP : 51.50 (-0.37%)
GE : 13.60 (+0.22%)
Merck (MRK) to Help J&J Make COVID-19 Vaccine to Boost Supply

Merck (MRK) will use its existing facilities to manufacture and supply J&J's newly approved COVID-19 vaccine.

JNJ : 156.10 (+1.98%)
PFE : 34.39 (+0.56%)
MRK : 73.13 (+1.33%)
MRNA : 132.19 (-0.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA-...

See More

Key Turning Points

3rd Resistance Point 150.42
2nd Resistance Point 142.34
1st Resistance Point 137.27
Last Price 132.19
1st Support Level 124.12
2nd Support Level 116.04
3rd Support Level 110.97

See More

52-Week High 189.26
Last Price 132.19
Fibonacci 61.8% 124.34
Fibonacci 50% 104.28
Fibonacci 38.2% 84.23
52-Week Low 19.31

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar